APTN — ADAPTIN BIO, INC.
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1938571 ·
Last close
$6.27
Market Cap
—
52W High
$6.27
52W Low
$6.27
ADV30
100
Next earnings
—
No quarterly fundamentals indexed for this ticker.
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $226.05B | $418.13 | — |
| GILD | GILEAD SCIENCES, INC. | $188.73B | $152.21 | — |
| MRNA | Moderna, Inc. | $78.76B | $197.28 | — |
| ARGX | ARGENX SE | $60.46B | $972.25 | — |
| RVMD | Revolution Medicines, Inc. | $43.24B | $201.74 | — |
News headlines (Yahoo Finance, 1h cache)
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
2026-09-18 12:35 · Yahoo
Life Sciences Virtual Investor Forum Agenda Announced
2026-09-14 12:35 · Yahoo
Adaptin Bio Announces Opening of Enrollment in a Phase 1 Clinical Trial Evaluating Treatment of Malignant Brain Tumors with APTN-101
2026-08-20 20:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.